Silence Therapeutics plc (SLN)

Silence Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	109.48	54.03	54.82	73.54	27.45	13.52
Short-Term Investments	40.11	-	16.33	-	10	20
Cash & Short-Term Investments	149.59	54.03	71.14	73.54	37.45	33.52
Cash Growth	197.87%	-24.05%	-3.25%	96.37%	11.73%	26.30%
Accounts Receivable	1.69	0.23	0.92	0.33	29.31	0
Other Receivables	12.85	18.61	16.43	8.16	4.21	3.51
Receivables	14.54	18.83	17.34	8.49	33.52	3.52
Prepaid Expenses	-	8.16	8.2	4.31	3.94	0.43
Other Current Assets	12.24	-	-	-	1.49	-
Total Current Assets	176.38	81.02	96.69	86.33	76.4	37.47
Property, Plant & Equipment	1.69	1.81	2.2	1.94	1.13	0.61
Long-Term Investments	0.28	0.28	0.28	0.3	0.3	0.28
Goodwill	7.66	7.84	8.01	7.59	8.13	7.69
Other Intangible Assets	0.27	0.28	0.32	0.02	0.02	0.03
Other Long-Term Assets	2.36	2.58	-	-	-	-
Total Assets	188.64	93.82	107.5	96.19	85.97	46.08
Accounts Payable	14.99	2.63	3.19	4.07	2.29	1.79
Accrued Expenses	-	9.43	8.86	6.53	5.91	5.1
Current Portion of Leases	0.18	0.18	0.45	0.14	0.34	0.29
Current Income Taxes Payable	-	0.37	0.59	0.19	-	-
Current Unearned Revenue	2.77	5.16	8.86	4.25	17.04	2.48
Total Current Liabilities	17.94	17.77	21.94	15.17	25.58	9.65
Long-Term Leases	-	0.09	-	-	-	-
Long-Term Unearned Revenue	58.19	58.91	63.49	72.5	51.34	15.52
Total Liabilities	76.13	76.77	85.43	87.67	76.91	25.17
Common Stock	7.02	5.94	5.39	4.49	4.17	3.92
Additional Paid-In Capital	356.88	251.45	226.67	184.33	153.73	138.15
Retained Earnings	-320.15	-304.61	-263.26	-222.97	-184.22	-152
Comprehensive Income & Other	68.76	64.27	53.28	42.67	35.38	30.84
Shareholders' Equity	112.51	17.05	22.07	8.53	9.06	20.91
Total Liabilities & Equity	188.64	93.82	107.5	96.19	85.97	46.08
Total Debt	0.18	0.27	0.45	0.14	0.34	0.29
Net Cash (Debt)	149.41	53.76	70.7	73.4	37.11	33.23
Net Cash Growth	199.68%	-23.96%	-3.68%	97.80%	11.67%	25.22%
Net Cash Per Share	3.58	1.45	2.20	2.48	1.36	1.33
Filing Date Shares Outstanding	46.8	46.5	35.95	29.93	27.77	26.12
Total Common Shares Outstanding	46.8	39.62	35.94	29.93	27.77	26.12
Working Capital	158.43	63.25	74.74	71.17	50.82	27.81
Book Value Per Share	2.40	0.43	0.61	0.28	0.33	0.80
Tangible Book Value	104.58	8.93	13.74	0.91	0.92	13.18
Tangible Book Value Per Share	2.23	0.23	0.38	0.03	0.03	0.50
Machinery	-	5.06	4.99	5.11	4.07	3.4

Source: S&P Capital IQ. Standard template. Financial Sources.